Molecular features of doxorubicin-resistance development in colorectal cancer CX-1 cell line

Autor: Rimantas Daugelavičius, Sonata Jarmalaitė, Indrė Šulskytė, Raimonda Kubiliūtė, Kristina Daniūnaitė
Jazyk: angličtina
Rok vydání: 2016
Předmět:
0301 basic medicine
Oncology
Homeobox protein NANOG
medicine.medical_specialty
Cell
Biology
Epigenesis
Genetic

03 medical and health sciences
CX-1
Cell Movement
Internal medicine
Cell Line
Tumor

Gene expression
medicine
Cell Adhesion
Humans
Topoisomerase II Inhibitors
Doxorubicin resistance
Gene
Oligonucleotide Array Sequence Analysis
Medicine(all)
lcsh:R5-920
Antibiotics
Antineoplastic

Gene Expression Profiling
Genes
p16

Cancer
DNA Methylation
medicine.disease
Colon cancer
Gene expression profiling
030104 developmental biology
medicine.anatomical_structure
Real-time polymerase chain reaction
Epithelial-to-mesenchymal transition
Doxorubicin
Drug Resistance
Neoplasm

Automotive Engineering
DNA methylation
Cancer research
lcsh:Medicine (General)
Colorectal Neoplasms
Genome-Wide Association Study
Zdroj: Medicina
Volume 52
Issue 5
Pages 298-306
Medicina, Vol 52, Iss 5, Pp 298-306 (2016)
Medicina; Volume 52; Issue 5; Pages: 298-306
ISSN: 1010-660X
DOI: 10.1016/j.medici.2016.09.003
Popis: Background and aim: Resistance to chemotherapy is the key obstacle to the effective treat- ment of various cancers. Accumulating evidence suggests significant involvement of the epithelial-to-mesenchymal transition (EMT) in the chemoresistance of most cancer types. This study aimed at analyzing the gene expression profile of doxorubicin (DOX)-resistant colorectal cancer cells CX-1. Materials and methods: DOX-resistant CX-1 cell sublines were acquired by stepwise increment of DOX concentrations in cell growth media. Global gene expression profiling was performed using human gene expression microarrays. The expression levels of individual genes were assessed by means of quantitative PCR (qPCR), while the DNA methylation pattern of several selected genes was determined by methylation-specific PCR. Results: Four DOX-resistant CX-1 sublines were established as a valuable tool for cell chemoresistance studies. Altered expression of the EMT, cell adhesion and motility, and chemoresistance-related genes was observed in DOX-resistant cells by genome-wide gene expression analysis. Besides, early and significant upregulation of the key EMT genes ZEB1 (5.8×
P <
0.001) and CDH2 (6.2×
P = 0.044) was identified by qPCR, with subsequent activation of drug transporter gene ABCC1 (3.3×
P = 0.007) and cell stemness gene NANOG (2.4×
P = 0.008). Downregulation of TET1 (2.1×
P = 0.041) and changes in the methylation status of the p16 gene were also involved in the acquisition of cell resistance to DOX.
Databáze: OpenAIRE